Callan Family Office’s Teradyne TER Stock Holding History

Callan Family Office’s Portfolio TER Stock Details TER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.4M	Sell	4,731 -24	-0.5%	-$6.69K	0.03%	461
2025 Q4	$920K	Buy	4,755 +1,158	+32%	+$199K	0.02%	571
2025 Q3	$495K	Sell	3,597 -250	-6%	-$27.3K	0.02%	538
2025 Q2	$346K	Buy	+3,847	New	+$307K	0.01%	721

Other funds holding TER

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Callan Family Office's TER Position: Q1 2026 in Review

Callan Family Office reduced its Teradyne (TER) stake by 0.5% in Q1 2026, selling an estimated $6.69K and leaving 4,731 shares worth $1.4M. The position accounts for 0.03% of the portfolio, ranked #461.

Callan Family Office first reported a position in TER in Q2 2025 and has held it in 4 quarters since. 1,223 funds tracked by Wall St. Rank hold TER as of Q1 2026.

Callan Family Office held 4,731 shares of Teradyne worth $1.4M as of Q1 2026.
Callan Family Office sold 24 Teradyne shares in Q1 2026, an estimated $6.69K.
Teradyne made up 0.03% of Callan Family Office's portfolio in Q1 2026, its #461 holding.
Callan Family Office first reported a position in Teradyne in Q2 2025 and has held it in 4 quarters since.
1,223 funds tracked by Wall St. Rank held Teradyne as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.